Can the first day of quetiapine therapy be administered as a single 100 mg dose instead of two 50 mg doses?

Day 1 Quetiapine Dosing: Single vs. Split Dose

No, the first day of quetiapine should not be given as a single 100 mg dose when treating schizophrenia or bipolar mania in adults—the FDA-approved dosing explicitly requires divided dosing on Day 1. 111

FDA-Approved Day 1 Dosing by Indication

Schizophrenia in Adults

• Day 1 requires 25 mg twice daily (total 50 mg/day), not a single 100 mg dose. 111
• The titration schedule then increases to 25–50 mg divided two or three times daily on Days 2 and 3, reaching 300–400 mg by Day 4. 111
• This gradual split-dose approach minimizes orthostatic hypotension and sedation during the critical initiation period. 23

Bipolar Mania in Adults

• Day 1 dosing is twice daily totaling 100 mg (e.g., 50 mg twice daily), which is still divided dosing—not a single 100 mg dose. 111
• Day 2 advances to twice daily totaling 200 mg, Day 3 to 300 mg, and Day 4 to 400 mg. 111
• Research confirms that rapid dose escalation to 400 mg by Day 4 is well tolerated when using this divided-dose schedule, with 92% of patients reaching 400 mg/day by Day 4 in clinical trials. 4

Adolescent Schizophrenia (13–17 years)

• Day 1 is 25 mg twice daily, identical to adult schizophrenia dosing. 111
• Day 2 increases to twice daily totaling 100 mg, then 200 mg on Day 3,300 mg on Day 4, and 400 mg on Day 5. 111

Pediatric Bipolar Mania (10–17 years)

• Day 1 is 25 mg twice daily, with the same gradual escalation as adolescent schizophrenia. 111

Why Divided Dosing Matters on Day 1

• Orthostatic hypotension risk is highest during initiation, particularly in elderly, debilitated, or hepatically impaired patients. 23111
• Quetiapine causes dose-dependent sedation and dizziness, which are mitigated by splitting the dose and allowing the patient to titrate exposure gradually throughout the day. 23
• The ESMO delirium guideline recommends even lower starting doses (25 mg stat, then every 12 hours if needed) in vulnerable populations such as older adults and those with hepatic impairment. 23

Special Populations Requiring Even Lower Day 1 Doses

Elderly Patients

• Start at 50 mg once daily (not 100 mg), then increase in 50 mg/day increments based on response and tolerability. 111
• Slower titration and lower target doses are mandatory due to predisposition to hypotensive reactions. 111

Hepatic Impairment

• Start at 25 mg once daily, then increase daily in 25–50 mg increments to an effective dose. 111

Delirium or Palliative Care

• The ESMO guideline recommends 25 mg oral stat as the initial dose, with scheduled dosing every 12 hours only if persistent symptoms require it. 23
• This is substantially lower than the 100 mg single dose proposed in the question. 23

Common Pitfalls to Avoid

• Do not administer 100 mg as a single dose on Day 1 for schizophrenia or bipolar mania—this deviates from FDA labeling and increases the risk of orthostatic hypotension, falls, and excessive sedation. 111
• Do not skip the divided-dose schedule even if the patient tolerates the first dose well—cardiovascular adaptation requires gradual titration. 23
• Monitor blood pressure regularly during the first week, especially in elderly patients, those on antihypertensives, or those with baseline orthostatic instability. 23

Efficacy Considerations

• The target therapeutic dose for acute mania is approximately 600 mg/day, with most responders receiving 400–800 mg/day by the end of treatment. 4
• Reaching 400 mg by Day 4 (bipolar mania) or Day 4 (schizophrenia) using the FDA-approved divided-dose schedule has been shown to be both effective and well tolerated in clinical trials. 4
• Quetiapine showed no significant benefit for relapse prevention in cannabis-induced psychosis, suggesting that efficacy is indication-specific and dose-dependent. 5